Press Releases on May 11, 2025 - EIN Presswire - Press Release Distribution Service

Published on May 11, 2025 - 14:00 GMT

Wall Street Icon Warns Elon Musk’s Dojo Marks the Start of a Post-Human Operating System

BALTIMORE, May 11, 2025 (GLOBE NEWSWIRE) -- According to former Wall Street strategist and technology analyst Enrique Abeyta, Elon Musk’s most ambitious project isn’t electric, orbital, or even physical—it’s cognitive. It’s called Dojo. Built around a …

Distribution channels: Banking, Finance & Investment Industry, Media, Advertising & PR ...

Published on May 11, 2025 - 13:52 GMT

Faruqi & Faruqi Reminds Avis Budget Group Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 24, ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Avis To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in Avis between …

Distribution channels: Consumer Goods, Law ...

Published on May 11, 2025 - 13:44 GMT

FDA Warns Companies Over Illegal Marketing of Botox and Related Products

For Immediate Release: November 05, 2025 The U.S. Food and Drug Administration issued 18 warning letters to owners of websites illegally marketing unapproved and misbranded botulinum toxin products, commonly called Botox. The agency is aware of adverse …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on May 11, 2025 - 13:44 GMT

FDA Warns Companies Over Illegal Marketing of Botox and Related Products

For Immediate Release: November 05, 2025 The U.S. Food and Drug Administration issued 18 warning letters to owners of websites illegally marketing unapproved and misbranded botulinum toxin products, commonly called Botox. The agency is aware of adverse …

Distribution channels: Food & Beverage Industry

Published on May 11, 2025 - 13:40 GMT

Faruqi & Faruqi Reminds Sana Biotechnology Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 20, ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Sana To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Sana between March 17 …

Distribution channels: Consumer Goods, Law ...

Published on May 11, 2025 - 13:36 GMT

Glowface - 11/03/2025

Recipient: Glowface United States Issuing Office: Center for Drug Evaluation and Research (CDER) United States Secondary Issuing Offices WARNING LETTER November 3, 2025 Glowface: This is to advise you that the United States (U.S.) Food and Drug …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on May 11, 2025 - 13:36 GMT

Derma Solution - 11/03/2025

Recipient: Derma Solution United States Issuing Office: Center for Drug Evaluation and Research (CDER) United States Secondary Issuing Offices WARNING LETTER November 3, 2025 Derma Solution: This is to advise you that the United States (U.S.) Food and Drug …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on May 11, 2025 - 13:35 GMT

MJS Medicals - 11/03/2025

Recipient: MJS Medicals South Korea Issuing Office: Center for Drug Evaluation and Research (CDER) United States Secondary Issuing Offices WARNING LETTER November 3, 2025 MJS Medicals: This is to advise you that the United States (U.S.) Food and Drug …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on May 11, 2025 - 13:35 GMT

Meamo - 11/03/2025

Recipient: Meamo South Korea Issuing Office: Center for Drug Evaluation and Research (CDER) United States Secondary Issuing Offices WARNING LETTER November 3, 2025 Meamo: This is to advise you that the United States (U.S.) Food and Drug Administration (FDA …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on May 11, 2025 - 13:34 GMT

Glam Derma - 11/03/2025

Recipient: Glam Derma Netherlands Issuing Office: Center for Drug Evaluation and Research (CDER) United States Secondary Issuing Offices WARNING LETTER November 3, 2025 Glam Derma: This is to advise you that the United States (U.S.) Food and Drug …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on May 11, 2025 - 13:34 GMT

COSMO KOREA - 11/03/2025

Recipient: COSMO KOREA South Korea Issuing Office: Center for Drug Evaluation and Research (CDER) United States Secondary Issuing Offices WARNING LETTER November 3, 2025 COSMO KOREA: This is to advise you that the United States (U.S.) Food and Drug …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on May 11, 2025 - 13:32 GMT

CelestaPro - 718613 - 11/03/2025

Recipient: CelestaPro United States Issuing Office: Center for Drug Evaluation and Research (CDER) United States Secondary Issuing Offices WARNING LETTER November 3, 2025 CelestaPro: This is to advise you that the United States (U.S.) Food and Drug …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on May 11, 2025 - 13:31 GMT

Faruqi & Faruqi Reminds The Bancorp Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 16, 2025 - ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In The Bancorp To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in The Bancorp …

Distribution channels: Consumer Goods, Media, Advertising & PR ...

Published on May 11, 2025 - 13:31 GMT

Korean Aesthetic dba Korean Fillers - 718842 - 11/03/2025

Recipient: Korean Aesthetic dba Korean Fillers United States Issuing Office: Center for Drug Evaluation and Research (CDER) United States Secondary Issuing Offices WARNING LETTER November 3, 2025 Korean Aesthetic dba Korean Fillers: This is to advise you …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on May 11, 2025 - 13:31 GMT

Estaderma - 718714 - 11/03/2025

Recipient: Estaderma South Korea Issuing Office: Center for Drug Evaluation and Research (CDER) United States Secondary Issuing Offices WARNING LETTER November 3, 2025 Estaderma: This is to advise you that the United States (U.S.) Food and Drug …

Distribution channels: Healthcare & Pharmaceuticals Industry